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Original paper ONE OF the difficulties in evaluating the effectiveness of naturopathic treatment lies in identifying the most appropriate research method to use. The conventional 
model of the double blind randomised trial, for example, is 
difficult to conduct within a patient-centred, holistic, therapeutic 
approach such as naturopathy.
Klaus (2000) argues that double blind randomised trials are 
appropriate where, for example, extensive knowledge of the 
action of a drug, is already known before trialling on humans. 
He recommends that the “evaluation should not focus on 
fastidious experimental research, but on critical and systematic 
observation of everyday practice”1.
Patient outcome measures have been used increasingly in 
conventional and complementary therapies2. By assessing the 
patient’s perception of any changes in health during treatment 
– “Am I better or worse since the treatment?” – the focus is on 
the patient’s assessment after treatment.
Thompson and Reilly used patient outcome measures 
successfully in a study to evaluate the impact of complementary 
therapies treatment (reflexology and homeopathy) on symptom 
control in cancer patients3.
MYMOP
The Measure Yourself Medical Outcome Profile (MYMOP) 
is a simple questionnaire, designed by Dr C. Paterson4, for 
measuring clinical outcomes assessed by the patients. It is a 
patient generated health status questionnaire that is symptom 
specific, but also considers the whole person by including the 
monitoring of a daily activity, and general wellbeing.
Since validation in 19964, MYMOP has been used successfully 
for evaluating patient outcomes for both allopathic and 
complementary therapy treatment5,6,7,8. MYMOP was adopted 
by the University of Westminster to assess patient outcomes in 
the teaching clinic.
Challenging cases
The University of Westminster Polyclinic is the largest 
subsidised multidisciplinary complementary therapies clinic 
in the UK offering 14 different therapies. The clinic in which 
naturopathy, osteopathy and craniosacral therapy are used 
opened in 2000.
Clinical outcome 
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focus), autism and hyperactivity (see Charts 3.1 and 
3.2).
Consultations were normally scheduled at 4-6 weeks 
for chronic conditions, but were seen earlier if the 
practitioner considered it appropriate.
The mMYMOP was administered at the beginning of 
each consultation. mMYMOP results were recorded by 
the practitioner, and entered into a computer database 
by a technician.
Data from a three-year period were analysed 
retrospectively and provided the basis for this pilot 
study. Data were used for all patients who had been 
treated in the clinic and who fulfilled the inclusion 
criteria (minimum attendance of two consultations), 
irrespective of length of treatment, outcome, or 
symptom.
Results
1. Analysis of the differences in scores between first 
consultation and latest consultation.
mMYMOP scores for the first consultation (before any 
treatment) and the latest consultation were collected. Initially, 
values for the differences in scores between the first consultation 
and the latest consultation were calculated by subtracting the 
latest score from the first consultation score for the presenting 
(first) symptom for each patient (see Graph 1).
This provided an indicator of any changes that may have 
occurred during treatment, and the direction of change. A 
negative score indicated a worsening of the symptom; a 
positive score indicated an improvement in the symptom as 
perceived by the patient.
Differences could potentially range from +6, when a patient 
rated their symptom to have originally measured the worst 
possible score (6), and on their latest consultation it had 
resolved (0), to -5, where a symptom had registered as being 
minor, and was aggravated by the treatment to “as bad as it 
could possibly be”. (A symptom was unlikely to start with a 
score of 0).
Analysis over a three-year period showed that out of 49 
patients 57.14 per cent (n=28) rated an improvement in their 
This clinic has attracted a wide range of patients and is fairly 
representative of private practice. In addition, because of its 
location within the public sector offering reduced fee treatment 
in central London, the clinic receives referrals from GPs and 
other organisations attracting challenging cases of mental 
and physical pathology. It is ideally suited to participate in 
an ongoing audit investigating the efficacy of complementary 
therapies using MYMOP.
The MYMOP form designed by Dr C Paterson4 was modified in 
the teaching clinic to facilitate easier use by students. Instead of 
using a visual analogue scale, ratings were recorded as numbers 
directly on the form and an additional space was added to 
record any life-affecting events, but otherwise the method 
remains the same.
The patient selects one or two related symptoms that they 
consider important (would like to improve), and an activity that 
is affected by the symptom(s); these are then rated on a Likert 
scale of: 6 for the worst possible score – e.g. very severe back 
pain, to 0 being best possible score – e.g. absence of back pain.
A rating for overall ‘Well being’ is also collected using the same 
scale. Modified MYMOP forms (mMYMOP) are completed 
at each consultation ensuring that any clinical changes are 
monitored.  A reduction in scores indicates an 
improvement in the patient’s rating of their own 
health, whereas any increase in scores indicates 
an adverse change. The patient consistently knew 
their ratings for their previous consultation before 
rating any current symptom changes.
Data collection
mMYMOP data collection started in June 2001, 
and is ongoing, for all patients. Data are collected 
for the full course of treatment.  The naturopathy, 
osteopathy and craniosacral therapy clinic runs 
on two days each week, in which the experienced 
practitioner assesses and treats the patient. Students 
observe within each consultation. A range of 
conditions were treated: neck, shoulder, and back 
problems, headaches, joint problems, emotional, 
and functional problems (e.g. depression, lack of 
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treatment presented with physical 
symptoms, and 43 per cent presented 
with mental/emotional symptoms. See 
charts 3.1 and 3.2 for the distribution 
and range of symptoms treated.
Discussion
This was the first attempt to analyse 
mMYMOP data from the University 
of Westminster clinic. The study had 
a dual purpose: 1. To investigate the 
efficacy of treatment in the clinic
2. To provide an opportunity to 
identify potential improvements in 
data collection.
mMYMOP was found to be simple, 
quick and easy to administer. However 
mMYMOP needs to be evaluated as 
a suitable tool to measure outcomes. 
A reliable measure can be obtained 
by averaging the severity of patients’ symptoms, with their 
associated affected activities, and overall well being. This 
provides a robust subjective measure for assessing changes in 
patient outcomes (see Graph 2 and Table 2). The mMYMOP 
forms used have space to record changes in circumstances that 
are likely to affect patient outcomes e.g. bereavement.
Larger sample sizes should limit the affect of external factors 
on data analysis.
It is important not to lose sight of the longer term beneficial 
effects of treatment. mMYMOP can measure changes in the 
patient’s health at a given time. It would also be useful to 
measure any changes in health after a longer period of time. 
A longitudinal (follow up) survey of patients is planned for the 
future.
first symptom (see Graph 1) and 34.69 per cent rated an 
improvement in their overall wellbeing score.
2. Analysis of Averaged Scores for Each Patient.
A more reliable measure of overall change in patient symptoms 
was calculated by averaging the patients’ scores for their 
symptoms, the activities affected by the symptoms, and overall 
well-being (see Graph 2). Patients who had omitted to rate 
related activities were excluded from the data sample, reducing 
the sample size to 46.
The averaged results showed that the improvement in patients’ 
health scores was highly significant at the p<0.001 (n=46). 
These results were highly unlikely to have happened by chance, 
the probability being less than 1 in 1000. Identical high levels of 
significance were repeated when analysing all the data by using 
a matched pairs T test. 
Before treatment 37 per cent of the sample (n=46) rated their 
symptoms as 3 or less. After treatment 78.3 per cent of patients 
rated their symptoms as 3 or less, demonstrating a decrease in 
scores and severity for the same symptoms.
The results demonstrate that patients attending the clinic 
perceive that their health improved, and that it is very unlikely 
(probability of less than 1 in 1000) that the improvement could 
have occurred by chance alone.
3) The Profile of Symptoms 
Symptoms were divided into two categories of physical, and 
mental/emotional. Fifty-seven per cent of patients who received 
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Table 2 (above) shows the changes in Means, 
Medians and Modes for Combined Averaged 
Patient Data
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What about the other 26 per cent patients who did not improve? 
This is the challenge of audit. mMYMOP scores were taken 
at the latest consultation, and some patients would not have 
completed their treatment. The consultations were held in a 
teaching clinic with students observing the treatment. The 
presence of students can impact on the therapist’s ability 
to maintain complete attention on the patient and this may 
therefore have an effect on the treatment outcome.
Scores were not available for those patients who discontinued 
treatment. Did their symptoms resolve, or did they opt out for 
different reasons? In future, patients who do not return will be 
asked to complete a mMYMOP form by post.
Analysis of time intervals between consultations would be 
useful. It seems probable from the results, that the type of 
presenting symptom dictates the timescale of treatment. 
Further examination of the patients’ cases should inform future 
practice.
While it is unreasonable to expect 100 per cent patients to 
improve, particularly with maintaining causes, there is always 
room for improvement.
Conclusions
The analysis proves conclusively that patients treated in the 
clinic felt that their symptoms improved. Patients scored 
significant improvements in their health irrespective of the 
classification of their presenting symptom. The mMYMOP was 
swift and easy to administer, and it has demonstrated usefulness 
as a tool for measuring patients’ treatment outcomes.
The data showed 73.9 per cent patients experienced an 
improvement in their symptoms. An average of all the 
information gathered for each patient (symptom, related 
activity, and wellbeing), and for each component part 
(presenting symptom, and wellbeing) showed highly significant 
improvements at p<0.001 level.
The report on complementary and alternative medicine by the 
House of Lords Select Committee on Science and Technology9 
recommends that research into complementary medicine 
should be undertaken to establish an evidence base.
This article is submitted to encourage other naturopaths in 
practice to consider introducing the use of patient outcome 
measures into their practice.
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